Compare Cerus Corporation vs CU Medical Systems
Customers evaluate the quality of Cerus Corporation's products using the following success metrics.
Overview
Cerus Corporation is 33 yrs old and is based in United States.
Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. Cerus currently markets the INTERCEPT Blood System for both platelets and plasma in Europe, Russia, the Middle East and selected countries in other regions around the world. The INTERCEPT red blood cell system is currently in clinical development.
CU Medical Systems is 23 yrs old and is based in South Korea.
CU Medical Systems (KRX: 115480) is engaged in the development, manufacturing, and marketing of defibrillators and cardiac monitors for hospital, pre-hospital, alternative care, and public access defibrillation use.
Demo Video
Leadership
Arnaud Besnard (Managing Director)
Ha-Rock Na (Chief Executive Officer)
Investors
Narragansett Asset Management, United Capital Management
JAFCO Asia
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Cerus Corporation has not claimed their profile.
Work for Cerus Corporation? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Cerus Corporation?
Claim your profile now.
Information not available because CU Medical Systems has not claimed their profile.
Work for CU Medical Systems? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for CU Medical Systems?
Claim your profile now.